Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Neoplasm Metastasis 3

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61pembrolizumab 60ribociclib 59Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Biological Assay × Clear all
NCT00551278 2016-01-12

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Janssen Diagnostics, LLC

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Janssen Diagnostics, LLC

Terminated
233 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Janssen Diagnostics, LLC

Terminated
461 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00869674 2013-05-30

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay China Registration Study

Johnson & Johnson Medical, China

Phase 3 Terminated
540 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡